Shengxin Lu

531 total citations
17 papers, 430 citations indexed

About

Shengxin Lu is a scholar working on Molecular Biology, Pharmacology and Biomedical Engineering. According to data from OpenAlex, Shengxin Lu has authored 17 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Biomedical Engineering. Recurrent topics in Shengxin Lu's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Immunotherapy and Immune Responses (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Shengxin Lu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Immunotherapy and Immune Responses (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Shengxin Lu collaborates with scholars based in China. Shengxin Lu's co-authors include Rimo Xi, Jinting Liu, Wei Liu, Yulan Zhang, Wei Liu, Yulan Zhang, Jingting Liu, Wei Liu, Yulan Zhang and Zhaozhen Cao and has published in prestigious journals such as Journal of the American Chemical Society, The Science of The Total Environment and Journal of Agricultural and Food Chemistry.

In The Last Decade

Shengxin Lu

16 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengxin Lu China 9 205 149 92 68 59 17 430
Gurmit Singh Canada 11 209 1.0× 135 0.9× 154 1.7× 87 1.3× 74 1.3× 16 557
Xueyan Cui China 17 414 2.0× 248 1.7× 32 0.3× 59 0.9× 112 1.9× 36 716
Kai Luo China 11 255 1.2× 168 1.1× 29 0.3× 17 0.3× 34 0.6× 44 476
Dongmei Qin China 17 125 0.6× 57 0.4× 62 0.7× 103 1.5× 134 2.3× 37 711
Sara Khalid India 13 117 0.6× 115 0.8× 44 0.5× 11 0.2× 95 1.6× 23 406
Şerife Evrim Kepekçi Tekkeli Türkiye 9 250 1.2× 111 0.7× 75 0.8× 7 0.1× 120 2.0× 37 557
Hossein Attar Iran 14 128 0.6× 122 0.8× 15 0.2× 29 0.4× 38 0.6× 28 476
Xiangdong Xu China 15 226 1.1× 145 1.0× 37 0.4× 40 0.6× 65 1.1× 47 575
Silvina V. Kergaravat Argentina 12 124 0.6× 70 0.5× 43 0.5× 74 1.1× 55 0.9× 19 336

Countries citing papers authored by Shengxin Lu

Since Specialization
Citations

This map shows the geographic impact of Shengxin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxin Lu more than expected).

Fields of papers citing papers by Shengxin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengxin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxin Lu. The network helps show where Shengxin Lu may publish in the future.

Co-authorship network of co-authors of Shengxin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengxin Lu. A scholar is included among the top collaborators of Shengxin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengxin Lu. Shengxin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sun, Xin, Jiayi Lin, Shengxin Lu, et al.. (2025). Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy. Journal of Controlled Release. 382. 113717–113717.
2.
Lin, Jiayi, Xiaokun Zhang, Xiaopan Yao, et al.. (2025). Delivery of Peptide-LYTAC via Polyporus Polysaccharide Microneedles for Targeted CD47 Degradation and Enhanced Tumor Immunotherapy. Journal of the American Chemical Society. 147(28). 25004–25016. 2 indexed citations
3.
Zhang, Xiao-kun, Ye Wu, Jiayi Lin, et al.. (2024). Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges. Acta Pharmaceutica Sinica B. 14(9). 3818–3833. 12 indexed citations
4.
Jin, Jinmei, Ye Wu, Jiayi Lin, et al.. (2024). Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy. Bioactive Materials. 43. 255–272. 11 indexed citations
5.
Liang, Rui, Shengxin Lu, Xiao-kun Zhang, et al.. (2024). Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy. International Journal of Biological Sciences. 20(7). 2779–2789. 8 indexed citations
6.
Lu, Shengxin, Xiao-kun Zhang, Jiayi Lin, et al.. (2024). Diselenide bond-stapled β-hairpin peptide-loaded hydrogel system for boosting oncolytic immunotherapy. Chemical Engineering Journal. 505. 159076–159076. 1 indexed citations
7.
Liu, Xiaoxia, Ting Yang, Jiayi Lin, et al.. (2023). [Stapled anoplin peptide combined with photothermal therapy enhances oncolytic immunotherapy of triple-negative breast cancer].. PubMed. 48(18). 4981–4992. 1 indexed citations
8.
Li, Weishi, et al.. (2023). Review of thermal treatments for the degradation of dioxins in municipal solid waste incineration fly ash: Proposing a suitable method for large-scale processing. The Science of The Total Environment. 875. 162565–162565. 38 indexed citations
9.
Lu, Shengxin, Jiayi Lin, Jinmei Jin, et al.. (2022). Tachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential. Expert Opinion on Drug Discovery. 17(12). 1407–1423. 8 indexed citations
10.
Cao, Zhaozhen, Meng Meng, Shengxin Lu, & Rimo Xi. (2011). Development of an Indirect Chemiluminescent Competitive ELISA to Detect Danofloxacin Residues in Milk. Analytical Letters. 44(6). 1077–1084. 7 indexed citations
11.
Cao, Zhaozhen, Shengxin Lu, Jinting Liu, et al.. (2011). Preparation of Anti-Lomefloxacin Antibody and Development of an Indirect Competitive Enzyme-Linked Immunosorbent Assay for Detection of Lomefloxacin Residue in Milk. Analytical Letters. 44(6). 1100–1113. 8 indexed citations
12.
Meng, Meng, et al.. (2010). Preparation of anti-salbutamol antibody based on a new designed immunogen and development of a heterologous indirect ELISA for detection of salbutamol residue.. PubMed. 45(4). 442–50. 3 indexed citations
13.
Liu, Zhongqiu, Shengxin Lu, Cui‐Hua Zhao, et al.. (2009). Preparation of anti‐danofloxacin antibody and development of an indirect competitive enzyme‐linked immunosorbent assay for detection of danofloxacin residue in chicken liver. Journal of the Science of Food and Agriculture. 89(7). 1115–1121. 25 indexed citations
14.
15.
Liu, Wei, et al.. (2007). Preparation of Anti-gatifloxacin Antibody and Development of an Indirect Competitive Enzyme-Linked Immunosorbent Assay for the Detection of Gatifloxacin Residue in Milk. Journal of Agricultural and Food Chemistry. 55(17). 6879–6884. 47 indexed citations
16.
17.
Lu, Shengxin, et al.. (2006). Preparation of anti-Pefloxacin Antibody and Development of an Indirect Competitive Enzyme-Linked Immunosorbent Assay for Detection of Pefloxacin Residue in Chicken Liver. Journal of Agricultural and Food Chemistry. 54(19). 6995–7000. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gurmit Singh Breakdown of academic impact, for papers by Xueyan Cui Breakdown of academic impact, for papers by Kai Luo Breakdown of academic impact, for papers by Dongmei Qin Breakdown of academic impact, for papers by Sara Khalid Breakdown of academic impact, for papers by Şerife Evrim Kepekçi Tekkeli Breakdown of academic impact, for papers by Hossein Attar Breakdown of academic impact, for papers by Xiangdong Xu Breakdown of academic impact, for papers by Silvina V. Kergaravat
Rankless by CCL
2026